Lupin has informed that the Allotment Committee of Directors at its meeting held today on October 23, 2024, allotted 51609 fully paid-up equity shares of ?2 each. These shares have been allotted upon exercising of vested options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid-up capital of the Company has been increased to ? 91,23,89,842 consisting of 45,61,94,921 equity shares of ? 2 each.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1950.00 |
| Dr. Reddys Labs. | 1169.90 |
| Cipla | 1469.00 |
| Lupin | 2376.00 |
| Zydus Lifesciences | 1116.25 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: